FDA Approves First OTC Birth Control Pill

Statement from Beth Battaglino, Executive Director of RN-C, HealthyWomen, on access to oral contraception:

FDA approval of the first over-the-counter (OTC) progestin-only oral contraceptive, Opill, is an important step in dramatically increasing access to birth control across the country. Reflecting the robust body of scientific evidenceHealthyWomen supports access to over-the-counter hormonal contraceptives for women and people assigned female at birth and the right of all people to access comprehensive sexual and reproductive health services to make decisions that meet their own needs .

Although some legislative approaches have increased access in some states, requirements such as pharmacy out-of-pocket still remain. barriers for many. Given scientific evidence showing that access to over-the-counter contraceptives can be achieved safely, FDA approval will help mitigate barriers, allowing more people to control their own reproductive futures, including avoiding pregnancy. not planned.

However, Opill must be affordable, an important factor in ensuring that women, especially those without health insurance, can access this new option.

HealthyWomen will continue to provide leadership through policy advocacy and consumer and HCP education, and by supporting research related to innovative strategies to expand access, safety, and affordability of hormonal contraceptives.